Both OCCI and CCIF exhibit leverage above 42% and non-leverage expenses near 30%, pressuring NAV and dividend sustainability.

Generate Biomedicines’ IPO aims to fund Phase 3 GB-0895 for severe asthma/COPD and expand its pipeline. Learn more about GENB ...

Auto components manufacturer Dhoot Transmission has pre-filed its draft red herring prospectus (DRHP) with market regulator ...

Epstein sought to use his own genetic material for regenerative medicine, following his conviction for soliciting ...

Moltbook has been described as being akin to the online forum Reddit for AI agents. The name comes from one iteration of ...

Elon Musk is joining his space exploration and artificial intelligence ventures into a single company before a massive ...

We have a pretty stellar line up of Oscar nominations, this year. The question is, who will win? And of course, who SHOULD ...

South Korea’s KBank has filed 13 trademarks for stablecoin wallet services as it ramps up digital asset plans ahead of a ...

DNOW shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...

Hong Kong's securities regulator is clamping down on poor quality listing documents after identifying some "serious ...

Bitcoin sees rising exchange inflows and sustained supply pressure as price trades near $78,000. BTC 14-day RSI fell into deeply oversold territory.